Human papillomavirus vaccine bivalent (Cadila healthcare)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman papillomavirus vaccine bivalent (Cadila healthcare)
Drug Alias NameBivalent Human Papillomavirus (Types 16 L1 & 18 L1)HPV vaccine-Cadila Healthcare
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A